Holdings
Atlas Venture Life Science Advisors, LLC
As of Jun 30, 2026, Atlas Venture Life Science Advisors, LLC reported 7 positions worth US$881M. Largest: Kymera Therapeutics, Inc., Dyne Therapeutics, Inc. and Sionna Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 2.85M | US$327M | −1.73M | Jun 30, 2026 |
| Dyne Therapeutics, Inc. | 6.8M | US$151M | −2.33M | Jun 30, 2026 |
| Sionna Therapeutics, Inc. | 3M | US$132M | no change | Jun 30, 2026 |
| Kailera Therapeutics, Inc. | 5.17M | US$114M | new | Jun 30, 2026 |
| Disc Medicine, Inc. | 1.51M | US$111M | no change | Jun 30, 2026 |
| Q32 Bio Inc. | 2.72M | US$34.6M | +625K | Jun 30, 2026 |
| Korro Bio, Inc. | 963K | US$12.7M | −174K | Jun 30, 2026 |